Gilead Sciences GILD Earnings Call Transcripts

NASDAQ GILD
$161.23 +2.03 (+1.28%)
As of: Oct 29, 2026 · 2:30 PM EDT
25 earnings calls on file for Gilead Sciences, from Q4 2019 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Gilead Sciences Q1 2026 Earnings Call

May 7, 2026 8,360 words · 36 min read
  • Daniel O'DayChairman and Chief Executive Officer
  • Johanna MercierChief Commercial Officer
  • Dietmar BergerChief Medical Officer
  • Andrew DickinsonChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Gilead Sciences Earnings Call Transcripts

Calls25
LatestMay 7, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 25 Gilead Sciences transcripts Register to get access to Gilead Sciences’s earnings call transcripts.